ERC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 6 (1) 109-115    DOI: 10.1677/erc.0.0060109
Copyright © 1999 by the Society for Endocrinology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, J.
Right arrow Articles by Ho, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, J.
Right arrow Articles by Ho, Y.
Endocrine Related Cancer, Vol 6, Issue 1, 109-115
Copyright © 1999 by Society for Endocrinology


Articles

Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases

JD Lin, MJ Liou, TC Chao, HF Weng, and YS Ho


From 1977 through 1995, 1,013 thyroid carcinoma patients received treatment and were followed up at Chang Gung Medical Center in Taiwan. To evaluate the prognostic variables of papillary and follicular thyroid carcinomas with limited lymph node metastases, a retrospective review of these patients was performed. Of these patients, 910 had papillary or follicular thyroid carcinoma, and 119 patients were categorized as clinical stage 2 with limited neck lymph node metastases only at the time of diagnosis. The patients were categorized into two groups as no recurrence and local recurrence or distant metastasis at the end of 1997. After the operations, radioactive iodide (131I) treatments were performed in 114 patients and external radiotherapy for neck region or distant metastases in 18 patients. The median follow-up period of these patients was 5.4 years. Clinical variables were coded in our computer for statistical analysis. After the treatments, 93 patients remained disease-free; 10 were in stage 2; 5 in stage 3; and 11 aggravated to stage 4. Of the clinical variables, age, post-operative first 1311 uptake scans, and 1-month post-operative thyroglobulin levels revealed statistically significant differences between the group which improved and the group which did not. During the follow-up period, five patients died; three patients died of thyroid cancer and two died of intercurrent diseases. Patients with papillary thyroid carcinoma revealed a higher percentage of lymph node metastases. Although limited lymph node metastases did not influence survival rate, patients with poor prognostic factors need more aggressive treatment to avoid progression of the cancer.


This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
X. Lin, S. D Finkelstein, B. Zhu, and J. F Silverman
Molecular analysis of multifocal papillary thyroid carcinoma
J. Mol. Endocrinol., October 1, 2008; 41(4): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
L. S. Ward, S. L. Souza, and L. V. M. Assumpcao
The Impact of Nodal Metastases on Prognosis of Well-Differentiated Thyroid Cancer Suggests the Practice of Prophylactic Neck Dissection
Arch Otolaryngol Head Neck Surg, April 1, 2003; 129(4): 495 - 496.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. Wunderbaldinger, M. G. Harisinghani, P. F. Hahn, G. H. Daniels, K. Turetschek, J. Simeone, M. J. O'Neill, and P. R. Mueller
Cystic Lymph Node Metastases in Papillary Thyroid Carcinoma
Am. J. Roentgenol., March 1, 2002; 178(3): 693 - 697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society for Endocrinology.